Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 3
---
 registered.

Our common shares are listed on The Nasdaq Capital Market (the "Nasdaq"), under the symbol "MDCX". The closing price of our common shares on Nasdaq on September 18, 2025 was $2.43.

We are an "emerging growth company" and a "smaller reporting company" under applicable U.S. Securities and Exchange Commission ("SEC") rules and will be eligible for reduced public company disclosure requirements. See"Prospectus Summary-Implications of Being an Emerging Growth Company" and "Prospectus Summary-Implications of Being a Smaller Reporting Company."

Investing in our securities involves risks. See "Risk Factors" beginning on page 10 of this prospectus to read about factors you should consider before buying our securities.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.

PURSUANT TO 17 C.F.R. SECTION 200.83

TABLE OF CONTENTS</div>

| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS                              | iii |
| PROSPECTUS SUMMARY                                                                     |   1 |
| THE OFFERING                                                                           |   7 |
| SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION                                 |   8 |
| RISK FACTORS                                                                           |  10 |
| DIVIDEND POLICY                                                                        |  46 |
| USE OF PROCEEDS                                                                        |  47 |
| MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION  AND RESULTS OF OPERATIONS |  48 |
| OUR BUSINESS                                                                           |  59 |
| MANAGEMENT                                                                             | 104 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                         | 130 |
| RELATED PARTY TRANSACTIONS                                                             | 132 |
| DESCRIPTION OF SECURITIES                                                              | 134 |
| CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS                                | 143 |
| SELLING SHAREHOLDERS                                                                   | 149 |
| PLAN OF DISTRIBUTION                                                                   | 155 |
| EXPERTS AND LEGAL MATTERS                                                              | 157 |
| ENFORCEMENT OF CIVIL LIABILITIES                                                       | 158 |
| WHERE YOU CAN FIND